The synthetic biology market is projected to reach USD 35.7 billion by 2027 from USD 11.4 billion in 2022, at a CAGR of 25.6% during the forecast period. The growth of this market is mainly driven by rise in demand for synthetic genes and synthetic cells, declining cost of DNA sequencing and synthesizing.
To know about the assumptions considered for the study download the pdf brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889
Synthetic biology is an interdisciplinary field that combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems, as well as to redesign existing biological systems for useful purposes.
Key components and segments of the synthetic biology market include:
Tools and Technologies: Companies in this segment develop and sell the tools and technologies necessary for synthetic biology research and applications. This includes DNA synthesis and sequencing, genome editing technologies like CRISPR/Cas9, and automation equipment.
Bioinformatics and Software: The field relies heavily on computational tools and software for designing and simulating biological systems. This segment includes companies that provide bioinformatics solutions for data analysis and modeling.
Applications: Synthetic biology has a wide range of applications, including healthcare (such as the development of engineered microbes for drug production), agriculture (creating genetically modified crops), and industrial processes (biofuel production, specialty chemical synthesis).
Startups and Biotech Companies: Many startups and biotechnology companies are actively engaged in synthetic biology research and development.
Academic and Research Institutions: Universities and research institutions play a significant role in advancing synthetic biology through fundamental research and education.
Regulatory Environment: Given the potential implications of synthetic biology, regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have been developing guidelines to ensure safety and ethical considerations are addressed.
Browse Complete Report along with TOC @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
Key Market Players
The prominent players operating in the synthetic biology market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), and Ginkgo Bioworks (US).
Thermo Fisher Scientific (US) is one of the leading player in synthetic biology market. The company’s leading position attributable to its diversified product portfolio, strong geographic presence, and adoption of organic and inorganic growth strategies. The company has adopted different growth strategies, such as new product launches and deals that include agreements, partnerships, acquisitions, and expansions, to maintain its leading position in the synthetic biology market.
Merck KGaA (Germany) is one of the leading players in the life sciences market. The company, through its acquisition of Sigma-Aldrich (US) in November 2015, entered the synthetic biology market. The life sciences division of Sigma offers oligonucleotides, CRISPR genome editing reagents, custom-engineered cell lines, and metabolic assays in the synthetic biology market. The strength of Sigma-Aldrich lies in its global reach. The company has its footprint in 37 countries and manages to reach its customers through its eCommerce platform.
Asia Pacific is likely to grow at higher double digit during the forecast period.
The Asia Pacific region is estimated to grow at the highest CAGR in the synthetic biology market during the forecast period, this is mainly due to factors such the increasing investment in research & development, emergence of new market players in synthetic biology market.
Synthetic Biology Market Dynamics:
Drivers:
Restraints:
Opportunities:
Challenges:
Complete The Payment and Get the Full Access of Report@ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=889
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Aashish MehraEmail: Send EmailPhone: 18886006441Address:630 Dundee Road Suite 430City: NorthbrookState: IL 60062Country: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
